医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

TOMI™ Environmental Solutions, Inc. Announces Expansion into the Philippines Healthcare Market via an Agreement with Espire Health Philippines, Inc.

2015年03月02日 PM11:00
このエントリーをはてなブックマークに追加


 

BEVERLY HILLS, Calif.

TOMI Environmental Solutions, Inc. (“TOMI” or “the “Company”) (OTCQB: TOMZ), a global bacteria and infectious disease control company, announced today that it has entered into a sales agency agreement with Espire Health Philippines, Inc. (“Espire Health”). This agreement will support and deliver TOMI’s SteraMist suite of products to three Cancer Treatment Specialist Centers in the Philippines. Espire Health has been contracted to build, own and operate the three centers, which form the first part of President Benigno Aquino III’s Health Reform Strategy for the Philippines. Espire Health is in partnership with the Department of Health under the Public Private Partnership program.

Dr. Halden Shane, TOMI’s Chief Executive Officer, stated, “TOMI is excited to work with Espire Health along with adding the Philippines to TOMI’s gold standard Healthcare Associated Infections (‘HAIs’) control program. TOMI’s SteraMist program has successively and consistently demonstrated a significant reduction in HAIs in hospitals in other countries. TOMI is also pleased to announce that Espire Health’s first order was received, has cleared customs and is currently being incorporated as a standard protocol for maintaining a sterile environment within the Cancer Treatment Centers. This will be essential for the well-being of patients undergoing treatment.

SteraMist’s Binary Ionization Technology (“BIT”) is a state-of-the-art international decontamination technology that uses a low-percentage hydrogen peroxide which is passed through an atmospheric cold plasma arc to produce a Reactive Oxygen Species (“ROS”) that kills or inactivates mold, bacteria and viruses, including hard-to-kill bacterial spores. This process leaves no residue and converts to only oxygen and water, which is considered eco-friendly.

Robert L.L. Relova III, Project Director of Espire Health, stated, “SteraMist will be incorporated and used in all critical care, operatory, dialysis, treatment, infusion and radiological areas. SteraMist will also be recommended as part of the country’s Ebola & MERS control program.” Mr. Relova is recognized as a renowned medical technocrat. Mr. Relova further stated, “I have always strived to seek and find the world’s leading technologies for many industries. All results and tests support SteraMist as the premier mechanical cleaning device to control HAIs and to reduce the turnover time in the field of hospital hygienic cleaning. SteraMist’s results will significantly benefit the patients and healthcare workers.”

About Espire Health Philippines, Inc.

Espire Health Philippines, Inc. (“Espire Health”) is a Philippines-based company specializing in the health industry. It has associate companies based in Singapore, Malaysia and Hong Kong with regional offices in Kuala Lumpur and Singapore. Espire Health’s prime objective is the development of specialized treatment centers and services such as Hospital Information Systems, Sterilization and Decontamination, Operations and Facility Management. Through this network of partnerships within the region, Espire Health combines access to international investors and medical experts in developing a “Gold Standard” in healthcare systems and operations for the Asian market.

About TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions, Inc. (OTCQB:TOMZ) is a global bacteria decontamination and infectious disease control company providing green energy-efficient environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of hydrogen peroxide-based products that use BIT technology, a state-of-the-art technology for the production of its six-log mist represented by the TOMI SteraMist brand.

TOMI’s products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for food safety in meat and produce processing facilities, military barracks and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association and The International Ozone Association. For additional product information, visit www.tomiesinc.com or contact us at info@tomiesinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

For additional product information, visit www.tomiesinc.com or contact the Company at info@tomiesinc.com.

CONTACT

TOMI Environmental Solutions, Inc.
Investor Relations:
JP
Fortune Group
Larry Fortune, 949-344-0539
or
John T.
Hillman
Director of Investor Relations
310-255-4438
or
Media
Relations:
TOMI Environmental Solutions, Inc.
Aaron Loveland
Senior
VP of Marketing and Public Affairs
301-686-8317

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • Bristol-Myers Squibb Granted Exclusive License by Ono Pharmaceutical for Multiple Programs Targeting Immuno-Suppressive Factors in the Tumor Microenvironment
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer